FDA Approves Second CAR T-Cell Therapy for Lymphoma

FDA has approved tisagenlecleucel (Kymriah) for certain kinds of non-Hodgkin lymphoma. Read about the trial that led to the approval and what the approval means for people with lymphoma.

Cancer Currents: An NCI Cancer Research Blog